2-Year Outcomes Of Phase Iib, Randomized, Double-Blind Trial Of GC4419 Versus Placebo To Reduce Severe Oral Mucositis Due To Concurrent Radiotherapy And Cisplatin For Head And Neck Cancer

C.M. Anderson; C.M. Lee; D. Saunders; A.E. Curtis; N. Dunlap; C. Nangia; A. Lee; S.M. Gordon; P. Kovoor; V. Bar Ad; A. Peddada; K.T. Colvett; D.M. Blakaj; M. Bonomi; F. Worden; J. Holmlund; J. Brill; M. Downs; S.T. Sonis; J. Buatti

doi:10.1016/j.ijrobp.2020.07.260

Back

2-Year Outcomes Of Phase Iib, Randomized, Double-Blind Trial Of GC4419 Versus Placebo To Reduce Severe Oral Mucositis Due To Concurrent Radiotherapy And Cisplatin For Head And Neck Cancer

Abstract

Open access

2-Year Outcomes Of Phase Iib, Randomized, Double-Blind Trial Of GC4419 Versus Placebo To Reduce Severe Oral Mucositis Due To Concurrent Radiotherapy And Cisplatin For Head And Neck Cancer

C.M. Anderson, C.M. Lee, D. Saunders, A.E. Curtis, N. Dunlap, C. Nangia, A. Lee, S.M. Gordon, P. Kovoor, V. Bar Ad, …

International journal of radiation oncology, biology, physics, Vol.108(3), pp.e789-e789

11/01/2020

DOI: 10.1016/j.ijrobp.2020.07.260

Files and links (1)

url

https://doi.org/10.1016/j.ijrobp.2020.07.260View

Published (Version of record) Open Access

Details

Title: Subtitle: 2-Year Outcomes Of Phase Iib, Randomized, Double-Blind Trial Of GC4419 Versus Placebo To Reduce Severe Oral Mucositis Due To Concurrent Radiotherapy And Cisplatin For Head And Neck Cancer
Creators: C.M. Anderson - University of Iowa
C.M. Lee - Cancer Care Northwest
D. Saunders - North East Cancer Centre, Health Sciences North, Northern Ontario School of Medicine, Sudbury, ON, Canada
A.E. Curtis - Spartanburg Regional Medical Center
N. Dunlap - University of Louisville/James Graham Brown Cancer Center, Louisville, KY
C. Nangia - UC Irvine Medical Center, Orange, CA
A. Lee - HOPE Cancer Center of East Texas, Tyler, TX
S.M. Gordon - East Carolina University, Greenville, NC
P. Kovoor - Texas Oncology, Plano West, Plano, TX
V. Bar Ad - Thomas Jefferson University, Philadelphia, PA
A. Peddada - Renown Regional Medical Center, Reno, NV
K.T. Colvett - Mountain States Health Alliance, Johnson City, TN
D.M. Blakaj - James Cancer Hospital and Solove Research Institute, The Ohio State University, Columbus, OH
M. Bonomi - James Cancer Hospital and Solove Research Institute, The Ohio State University, Columbus, OH
F. Worden - University of Michigan, Ann Arbor, MI
J. Holmlund - Galera Therapeutics, Inc., Malvern, PA
J. Brill - Galera Therapeutics, Inc., Malvern, PA
M. Downs - Statistics Collaborative, Inc., Washington, DC
S.T. Sonis - Primary Endpoint Solutions, Watertown, MA
J. Buatti - University of Iowa
Resource Type: Abstract
Publication Details: International journal of radiation oncology, biology, physics, Vol.108(3), pp.e789-e789
DOI: 10.1016/j.ijrobp.2020.07.260
ISSN: 0360-3016
eISSN: 1879-355X
Publisher: Elsevier Inc
Language: English
Date published: 11/01/2020
Academic Unit: Radiation Oncology; Pharmacy Practice and Science; Neurosurgery; Otolaryngology
Record Identifier: 9984304983402771

Metrics

20 Record Views